Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:562 (8 March), doi:10.1136/bmj.39510.443947.59
Des Spence, general practitioner, Glasgow
destwo@yahoo.co.uk
| The first 150 words of the full text of this article appear below. |
We clinicians have a stereotyped view of university academics: bearded cyclists, with sandals and odd terry socks, writing books that no one will read but that, fortunately, they never finish. But our academic comrades can enjoy a moment in the sun. Splashed across all the media, a recent meta-analysis of antidepressants concluded, after a reanalysis of unpublished data released through freedom of information legislation, that they are no better than placebo in all but severe cases of depression (BMJ 2008;336:466 doi: 10.1136/bmj.39503.656852.DB, 2008;336:532-4 doi: 10.1136/bmj.39504.662685.0F). The study seems to vindicate the position, held by many, that antidepressants are overprescribed. However, this isnt a time to say "we told you so" but an opportunity to reflect.
Leaving aside the merits (or lack thereof) of the study, why werent these conclusions available a decade ago? Private companies own the data from trials and have enormous vested interests in controlling
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses